Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,952 | 89,323 | 54,875 | 97,991 | 66,624 |
| Marketable Securities | 156,620 | 183,463 | 355,948 | 290,610 | 219,359 |
| Receivables | 73,066 | 25,807 | 8,458 | N/A | N/A |
| Inventories | 14,526 | 13,134 | 7,514 | N/A | N/A |
| TOTAL | $335,820 | $330,431 | $437,406 | $402,773 | $292,826 |
| Non-Current Assets | |||||
| PPE Net | 1,041 | 1,539 | 1,881 | 2,261 | 2,016 |
| Intangibles | 9,479 | 6,438 | 7,188 | 0 | 0 |
| Other Non-Current Assets | 2,549 | 2,957 | 2,799 | 3,118 | 3,427 |
| TOTAL | $13,069 | $10,934 | $11,868 | $5,379 | $5,443 |
| Total Assets | $348,889 | $341,365 | $449,274 | $408,152 | $298,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,220 | 11,992 | 8,827 | 7,353 | 7,140 |
| Accrued Expenses | 65,973 | 33,941 | 28,323 | 25,540 | 15,462 |
| TOTAL | $81,013 | $46,668 | $37,807 | $33,326 | $22,602 |
| Non-Current Liabilities | |||||
| Long Term Debt | 107,203 | 201,799 | 197,769 | 72,350 | N/A |
| Other Non-Current Liabilities | 3,132 | 4,231 | 4,117 | 4,799 | 5,046 |
| TOTAL | $110,335 | $206,030 | $201,886 | $77,149 | $5,046 |
| Total Liabilities | $191,348 | $252,698 | $239,693 | $110,475 | $27,648 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,638 | 96,813 | 61,083 | 50,380 | 50,085 |
| Common Shares | 12 | 9 | 6 | 5 | 4 |
| Retained earnings | -1,121,943 | -981,904 | -719,764 | -408,306 | -201,950 |
| Other shareholders' equity | -7 | 4 | -1,086 | -255 | -2 |
| TOTAL | $157,541 | $88,667 | $209,581 | $297,677 | $270,621 |
| Total Liabilities And Equity | $348,889 | $341,365 | $449,274 | $408,152 | $298,269 |